Latest news with #DepartmentofUrology
Yahoo
20-05-2025
- Health
- Yahoo
Biden's prostate cancer diagnosis prompts awareness for early screening
(WHTM) – According to the Pennsylvania Prostate Cancer Coalition, more than 13,000 Pennsylvanians will be diagnosed with prostate cancer in 2025, and nearly 1,500 will die. The coalition says only 33% of men ages 50+ keep up with routine screenings, and, unfortunately, it takes a well-known public figure like former president Joe Biden getting diagnosed to serve as a reminder. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Retired Col. James (Jim) Williams says a Prostate-Specific Antigen Test led to his prostate cancer diagnosis. 'This young doctor arbitrarily included in the blood work, something called PSA,' Williams says. Over 30 years later, he's cancer-free and Chairman of the Pennsylvania Prostate Cancer Coalition. Williams says Biden is a good example of why the digital rectal exam is important because that's how a small nodule was found in his prostate. Top Pennsylvania lawmakers took $119K in gifts, trips, and more from those seeking to influence them in 2024 'A physician can actually feel a portion of your prostate through the rectum more,' Williams says. 'It's a very uncomfortable 10-second test, but it could save your life.' Biden's personal office says the cancer spread to his bones. 'We are really no longer looking at a type of cancer that's necessarily curable, but it is highly treatable,' says Dr. Jay Raman, Chair of the Department of Urology at Penn State Health. Biden's cancer has a Gleason score of 9 on a scale of 6 to 10. 'High grade prostate cancer, like the Gleason 9, prostate cancer will grow rapidly and may spread quickly, so I'm not certainly implying that there was any sort of miss with regards to his diagnosis,' says Dr. Raman. 'At age 82, most guideline panels don't recommend routine screening for prostate cancer in men beyond 70 to 75 years of age.' Williams says routine screening is needed later in life. 'You need to go to the doctor when you're well, not when you're sick,' Williams says. 'Men take better care of their cars than they take care of their prostate.' Biden's office says that while the cancer is aggressive, it appears to be hormone-sensitive. 'President Biden is probably receiving treatment that reduces his testosterone levels, and that's starving the prostate cancer cells,' Dr. Raman says. Williams says the side effects of treatment will determine Biden's quality of life. Raman says Biden will likely have cancer for the rest of his life. 'I could very well foresee President Biden living for a number of more years on treatment without this impacting his life expectancy,' Raman says. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Upturn
02-05-2025
- Health
- Business Upturn
American Urological Association Names New Officers and Board Members
BALTIMORE, May 02, 2025 (GLOBE NEWSWIRE) — The American Urological Association (AUA) today announced the following new officers and members to its Board of Directors: Lane Palmer, MD, will serve as the 2025-2026 AUA president, having served as president-elect since May 2024. Dr. Palmer has served as chair of the AUA-SPU Task Force on Intersex and Transgenderism which has been instrumental in deterring efforts in passing legislation which would ban surgery on children with Intersex conditions during childhood and is a past-president of the AUA New York Section. He is currently a Professor of Urology and Pediatrics at the Zucker School of Medicine at Hofstra/Northwell and Chief of Pediatric Urology at Cohen Children's Medical Center of New York at Northwell Health. Eugene Y. Rhee, MD, MBA, has been named AUA 2025-2026 president-elect. Dr. Rhee served as AUA Public Policy chair from 2020 to 2024, was a graduate of the AUA Leadership Program and a distinguished AUA Gallagher Health Policy Scholar. Dr. Rhee currently holds dual leadership roles as Chief of Urology for Kaiser Permanente Southern California and Area Assistant Medical Director for Business Line & Finance for Kaiser Permanente San Diego. Stephen Y. Nakada, MD, FACS, FRCS, is now the immediate past president of the AUA. Dr. Nakada served as the AUA president from 2024 to 2025. He has also been President of the R.O.C.K. Society, the Society of Academic Urologists, the Endourological Society and the American Board of Urology. Dr. Nakada is currently a professor and chairman of the Department of Urology, and the David T. Uehling chair of Urology at the University of Wisconsin School of Medicine and Public Health in Madison, WI. Jennifer U. Miles-Thomas, MD, MBA, joins the AUA Board as Treasurer this year, serving as Treasurer-elect 2024-2025. Dr. Miles-Thomas has served as a mentor in the AUA Leadership Program, contributed to the AUA Leadership & Business Education Committee, hosted multiple AUA podcasts focused on the Business of Urology and sat on the Mid-Atlantic AUA Board of Directors. She is currently the Vice Chair of Regional Integration and Innovation in the Department of Urology at Northwestern Medicine. Adam S. Kibel, MD, MHCM, joins the Board as the New England Section Representative. His leadership positions include serving on the AUA Quality Council, the NCCN-Prostate Screening Guidelines Committee, the NCI Genitourinary Trial Steering Committee, the CALGB Executive Committee and President-elect of the Society of Urologic Oncology. Dr. Kibel is currently the chair of Urology at Mass General Brigham, the Elliott Carr Cutler professor of surgery at Harvard University, the DiNovi chair of Urology at BWH, the chair of the Harvard Residency Program (BWH) and Disease Center co-leader of the Dana Farber GU Oncology Program. Ronald P. Kaufman Jr., MD, joins the Board as the Northeastern Section Representative. Dr. Kaufman was a member of the inaugural AUA Leadership Program in 2004, was chair of the AUA Coding and Reimbursement Committee, served as a consultant to the AMA Current Procedural Terminology (CPT) Editorial Panel and is a past president of the New York State Urological Society and the Northeastern Section of the AUA. He is currently a Professor of Surgery in the Department of Urology at Albany Medical College in Albany, New York. The AUA would like to recognize and thank the Board members whose terms concluded on April 30, 2025. Randall Meacham, MD, has completed his years of presidential service along with regional Section Representatives, Arthur Tarantino, MD, from New England, Hassan Razvi, MD, from Northeastern, and former Treasurer, Thomas Stringer, MD. A full list of AUA Board members is now available at About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 26,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy. Attachment American Urological Association Names New Officers and Board Members Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Yahoo
21-02-2025
- Health
- Yahoo
Health hazards associated with hair dye exposure
NEW HAVEN, Conn. (WTNH) — In Friday's Health headlines, why hair dye exposure may be a health hazard and a potential cause of cancer. Dr. Michael Karellas, a urologic oncologist at Yale Cancer Center and the western region director for the Department of Urology at Yale School of Medicine joined Good Morning Connecticut at 9 a.m. to discuss. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
